Ind-Ra Webinar to discuss Risks in Acquisition of European Generic Businesses Partially Comforting to Indian Formulators

Webinar Invitation - Acquisition of European Generic Businesses Partially Comforting to Indian Formulators

India Ratings and Research invites you to a webinar to discuss its analysis on the potential acquisition opportunities facing Indian formulators due to the proposed sale of generic assets by global pharmaceutical majors in Europe. The agency believes that these acquisitions carry risks and may outweigh benefits targeted to counter near to medium term profitability concerns from US exposures. The report is based on agency's evaluation of the factors impacting current business operations and the performance of historical acquisitions made by Indian formulators in the European region over FY14-FY18.

https://lnkd.in/f3MNiVn

The webinar will have presentation by India Ratings analyst followed by a Q & A session for the audience.

Date - March 16, 2018 (Friday) 

Time - 4 PM onwards 

Speaker – 

Mr. Ankit Bhembre & Ankit Bhembre, Senior Analyst - Corporates

&

Mr. Karthikeyan T, Associate Director – Corporates at India Ratings and Research 

Registration is mandatory to attend the webinar. Request you to kindly use your work email address to register. To register, please follow this link – https://lnkd.in/fQEnyZx